Consultant in Medical Oncology – 3rd Dept of Medical Oncology, “Hygeia” hospital, Athens September 1, 2014 – present
Medical Oncology locum Sp. Reg.– Gynae/renal/melanoma unit (Dr. Susanna Banerjee) Royal Marsden Hospital, London Sept, 2013 –July, 2014
Medical Oncology Sp.Reg. – University of Athens, Medical School “ALEXANDRA” hospital, Department of Medical Oncology (Prof. A.M. Dimopoulos), May 26, 2011 – June 17, 2014
Internal Medicine SHO/Sp.Reg (including 6 months in Hematology) – University of Athens, Medical School, “LAIKO” University hospital (Prof. H. Moutsopoulos), June 20, 2008 – May 25, 2011.
Associate assistant in medical oncology private practice (Dr. E. Razis), May 2008 – Sept 9, 2013.
Post Graduate training program in Medical Oncology (attending with scholarship) Hygeia Hospital, 1st Department of Medical Oncology ( Dr. E. Razis) December 1, 2007 – April 1, 2008
Post graduate training course in Molecular Medicine (M.Sc.) Molecular Carcinogenesis group (Prof V. Gorgoulis), Department of Histology and Embryology, Medical School, University of Athens February 1, 2007 – May 31, 2008
Rural Community Service – General Hospital, Molaoi Lakonia, Greece, September 1, 2005 – January 31, 2007
Army Service – Medical Officer February 24, 2004 – November 24, 2004
Bevacizumab in high grade glioma: Is there a subgroup that benefits? G.Rigakos, A.Kyriazoglou, A.Vernadou, S.Papadopoulos, E.Skarpidi, P.Nomikos, C.Dardoufas, G.Nassioulas, G.Kouvatseas, O.Spyri, S.Labropoulos, E.Razis. (2017) Hematol Med Oncol, Volume 2(4): 1-7.
Extracranial and diffuse bone marrow metastases from Anaplastic Oligodendroglioma: a case report and review of the literature. A.Assi, A.Huang, G.Rigakos, S.Papadopoulos, Th.Georgiadis, E.Vrakidou, C.Dardoufas, S.Lampropoulos, P.Nomikos, E.Razis. Neuro-Oncology Practice (submitted 2016).
Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report. G.Rigakos, A.Vakos, S.Papadopoulos, A.Vernadou, A.Tsimpidakis, D. Papachristou, E.Razis Molecular and Clinical Oncology. 5: 263-266, 2016.
Neoplastic meningitis: clinical presentation, differential diagnosis, radiology, diagnosis. G.Rigakos, C.Liakou, N.Felipe, D.Orkoulas-Razis, E.Razis. Cancer Control (under press).
Unusual .mandibular metastasis of bladder cancer in a patient and two synchronous malignancies, bladder cancer and chronic lymphocytic leukemia, in a single lymph node. A case report. C.Liakou, M.Georgiou, T.Georgiadis, G.Rigakos, S. Lampropoulos, E.Razis. Case Reports in Clinical Pathology, 2015, Vol. 2, No. 4.
Brain Tumors. G.Rigakos, E.Razis. The Doctor. 2015:18:64-65.
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with wt-KRAS metastatic colorectal cancer treated with Cetuximab. E.Razis, G.Pentheroudakis, G.Rigakos, M.Bobos, G.Kouvatseas, O.Tzaida, T.Makatsoris, P.Papakostas, M.Bai, A.Goussia, E.Samantas, D.Papamichael, O.Romanidou, I.Efstratiou, E.Tsolaki, A.Psyrri, W.De Roock, D.Bafaloukos, G.Klouvas, S.Tejpar, K.T. Kalogeras, D.Pectasides, G.Fountzilas. Journal of Cancer Research and Clinical Oncology. 2014 Mar, doi: 10.1007/s00432-014-1626-2. Epub 2014 Mar 5.
Newer Therapeutic Agents for Urogenital System Tumors. F.Stavridi, G.Rigakos, E.Razis. Journal of Medical Annals (Hygeia Hospital Monthly Edition), 2012; 16(3): 791-795.
BRCAness: Finding the Achilles Heel in Ovarian Cancer. G.Rigakos E.Razis. Oncologist. 2012;17(7):956-62. Epub 2012 Jun 6.
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Razis E, Bobos M, Kotoula V, Eleftheraki AG, Kalofonos HP, Pavlakis K, Papakostas P, Aravantinos G, Rigakos G, Efstratiou I, Petraki K, Bafaloukos D, Kostopoulos I, Pectasides D, Kalogeras KT, Skarlos D, Fountzilas G. Breast Cancer Res Treat. 2011 Jul;128(2):447-56. Epub 2011 May 19.
Call us on 2106867000 to book an appointment with the medical specialist or the department you are interested in.
Our website uses cookies that are necessary for it to function. With your consent, we also use statistics and advertising cookies (Google, Meta), which are activated only if you accept them. You can change your choice at any time via “Cookies Manager”. Read more in our Cookies Policy. Accept allReject allSettings
Cookies Manager
Cookie Settings
We use cookies that are necessary for the website to function and, only with your consent, statistics and advertising cookies. Choose below which categories you accept. You can change or withdraw your choice at any time via “Cookies Manager”. Read more in our Cookies Policy.
Necessary for the website to function properly and for you to browse it. Without them, pages may not display correctly and some services may not be available. Cookies: viewed_cookie_policy, CookieLawInfoConsent, cookielawinfo-checkbox-* (they store your cookie choices, up to 1 year).
They help us understand how the website is used (e.g. which pages are visited most), so that we can improve it. We use Google Analytics and WordPress.com Stats (Jetpack). They are activated only with your consent. Cookies: _ga, _ga_ZL71G4M9G4 (Google, up to 2 years).
They are used to measure the effectiveness of our advertising and to show relevant ads on third-party platforms (Meta/Facebook, Google). They are activated only with your consent. Cookies: _fbp (Meta, 3 months), _gcl_au (Google, 3 months), as well as Google third-party cookies on doubleclick.net.